Lidocaína B. Braun

Lidocaine, the active ingredient in Lidocaína B. Braun, is a local anesthetic presented as a sterile solution for epidural, infiltration and intradermal use. It provides reversible nerve impulse blockade for analgesia and anesthesia in surgical and diagnostic procedures. GNH USA supplies Lidocaína B. Braun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Lidocaína B. Braun is a local anesthetic used in several procedural contexts. - Epidural analgesia: provides pain relief during labor or postoperative periods by blocking spinal nerve transmission. - Infiltration anesthesia for minor surgical procedures: numbs targeted tissue to allow painless incision or excision. - Intradermal skin testing: creates a temporary, localized numb area for allergy or diagnostic skin tests. - Local anesthesia for diagnostic or therapeutic procedures: facilitates painless endoscopic, catheter or biopsy interventions.

Lidocaína B. Braun may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Injection site pain: mild discomfort at the site of administration. - Redness or erythema: localized skin flushing. - Swelling or edema: temporary tissue swelling. - Itching or pruritus: mild skin irritation. - Dizziness or light‑headedness: transient sensation of imbalance. - Nausea: brief feeling of queasiness.

Serious or Rare Side Effects: - Systemic toxicity: CNS symptoms such as seizures, confusion, or tremor. - Cardiac arrhythmias: abnormal heart rhythms, including bradycardia or ventricular tachycardia. - Hypotension: sudden drop in blood pressure. - Allergic reaction: urticaria, angioedema, or anaphylaxis. - Methemoglobinemia: reduced oxygen‑carrying capacity of blood. - Persistent numbness: prolonged loss of sensation beyond expected duration.

When using Lidocaína B. Braun, clinicians should observe several safety measures. - Allergy assessment: verify no known hypersensitivity to amide‑type local anesthetics. - Dose minimisation: employ the lowest effective concentration for the intended procedure. - Cardiovascular monitoring: observe heart rate and blood pressure during epidural administration. - Avoid intravascular injection: aspirate before injecting to prevent systemic exposure. - Hepatic function: consider reduced clearance in patients with severe liver disease. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Lidocaína B. Braun can interact with other medicines, altering its safety profile.

Major Interactions (Avoid): - Class I antiarrhythmics (e.g., quinidine, procainamide): increase risk of cardiac conduction disturbances. - Other local anesthetics: additive toxicity leading to CNS or cardiac effects. - Drugs that lower seizure threshold (e.g., bupropion, tramadol): heighten risk of seizures.

Moderate Interactions (Monitor Closely): - CYP1A2 or CYP3A4 inhibitors (e.g., cimetidine, erythromycin): may raise lidocaine plasma levels. - Diuretics (e.g., furosemide): can reduce plasma protein binding, increasing free drug. - Hepatic enzyme inducers (e.g., rifampin, carbamazepine): may lower lidocaine concentrations, reducing efficacy.